Skip to main content
. 2021 Feb 12;11(2):e044420. doi: 10.1136/bmjopen-2020-044420

Table 2.

Primary and secondary outcomes for included and excluded participants


 Prostate cancer mortality All-cause mortality Systemic therapy Upstaging*
Included Localised
(T1/2 N0 M0)
n=10 901		 1250
(11.47%)		 3450
(31.65%)		 2331
(21.38%)		 45
(0.41%)
Excluded Invasive
(T3+/N1/M1)
n=12 318		 3894
(31.61%)		 6916
(56.15%)		 10 881
(88.33%)		 28
(0.23%)
Unknown
n=31 281		 1540
(4.92%)		 5420
(17.33%)		 31 954
(58.63%)		 19
(0.06%)

*Repeat staging data missing for 50 119 (91.96%) of sample.